Potential of modern nonopioid analgesics in the prevention and treatment of pain syndrome in decompressive stabilizing spine surgeries
- 作者: Lukonina T.1, Khoronenko V.1,2, Abuzarova G.1,3, Alekseeva G.4, Buharov A.1
-
隶属关系:
- Herzen Moscow Research Institute of Oncology — Branch of the National Medical Research Center of Radiology
- Peoples’ Friendship University of Russia named after Patrice Lumumba
- Russian Medical Academy of Continuous Professional Education
- National Medical Research Radiological Centre
- 期: 卷 18, 编号 2 (2024)
- 页面: 115-131
- 栏目: Original articles
- URL: https://journals.rcsi.science/1993-6508/article/view/262170
- DOI: https://doi.org/10.17816/RA628829
- ID: 262170
如何引用文章
详细
BACKGROUND: Secondary (tumor) lesion of the spine in 80% of cases is accompanied by chronic pain syndrome (CPS). A decrease in opioid subsidies in the postoperative period is important not only to prevent side effects, but also in order to create a reserve when providing palliative care for patients with CP, due to the pathology of the skeletal muscle system.
AIM: To optimize postop analgesia for cancer patients with CPS undergoing decompressive-stabilizing spine surgery.
MATERIALS AND METHODS: We included 52 patients aged 32–76 (average age: 59±10 [95% CI: 56–62]) years, 23 (44.2%) men and 29 (55.8%) women, with physical status according to the classification of patients of the American Society of Anesthesiologists I–III, CPS without therapy were included strong opioids for spinal metastases. Patients were randomized according to the type of postop analgesia: tramadol was used in the control group (group K) (n=15, 28.8%), a combination of diclofenac and orphenadrine in group D (n=18, 34.6%), and ibuprofen in group I (n=19, 36.5%). Postoperative pain intensity deduced using the visual analog scale was determined during extubation, transfer to a bed in the intensive care unit, 1 and 3 hours postop, and 21:00 on the day of surgery and 06:00 on day 2. The effect duration of the analgesic under study, the need for anesthesia on the postop day, and satisfaction with Likert anesthesia 1 hour after administration were evaluated.
RESULTS: Significant differences in the average values of pain intensity at rest at 06:00 on postoperative day 2 between groups D (Me=10) and K (Me=20) were obtained. Satisfaction with pain relief according to Likert scale in the groups was rated “excellent” or “good.” The duration of opioid therapy was significantly lower in the nonopioid groups (six postop days in groups I and D versus seven in group K; p=0.013).
CONCLUSIONS: Postop analgesia methods using nonopioid analgesics are effective and possess opioid-sparing potential.
作者简介
Tatyana Lukonina
Herzen Moscow Research Institute of Oncology — Branch of the National Medical Research Center of Radiology
编辑信件的主要联系方式.
Email: tatiyana.kretowa@yandex.ru
ORCID iD: 0009-0002-1203-2395
SPIN 代码: 7937-3507
俄罗斯联邦, Moscow
Victoria Khoronenko
Herzen Moscow Research Institute of Oncology — Branch of the National Medical Research Center of Radiology; Peoples’ Friendship University of Russia named after Patrice Lumumba
Email: khoronenko_mnioi@mail.ru
ORCID iD: 0000-0001-8845-9913
SPIN 代码: 1971-6546
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, Moscow; MoscowGuzal Abuzarova
Herzen Moscow Research Institute of Oncology — Branch of the National Medical Research Center of Radiology; Russian Medical Academy of Continuous Professional Education
Email: abuzarova_mnioi@bk.ru
ORCID iD: 0000-0002-6146-2706
SPIN 代码: 9876-4680
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, Moscow; MoscowGalina Alekseeva
National Medical Research Radiological Centre
Email: gs.alekseeva@nmirc.ru
ORCID iD: 0000-0001-8204-9032
SPIN 代码: 9119-8286
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, ObninskArtem Buharov
Herzen Moscow Research Institute of Oncology — Branch of the National Medical Research Center of Radiology
Email: artembuharov@mail.ru
ORCID iD: 0000-0002-2976-8895
SPIN 代码: 8349-0930
MD, Dr. Sci. (Med.)
俄罗斯联邦, Moscow参考
- Zaorsky NG, Wang X, Garrett SM, et al. Pan-cancer analysis of prognostic metastatic phenotypes. Int J Cancer. 2022;150(1):132–141. doi: 10.1002/ijc.33744
- Esperança-Martins M, Roque D, Barroso T, et al. Multidisciplinary approach to spinal metastases and metastatic spinal cord compression — a new integrative flowchart for patient management. Cancers. 2023;15(6):1796. doi: 10.3390/cancers15061796
- Ruchkin VN, Gantsev KSh. Osseal metastasis treatment. Creative surgery and oncology. 2010;(2):78–83. EDN: MSZOZF
- Oldenburger E, Brown S, Willmann J, et al. ESTRO ACROP guidelines for external beam radiotherapy of patients with complicated bone metastases. Radiother Oncol. 2022;173:240–253. doi: 10.1016/j.radonc.2022.06.002
- von Moos R, Body JJ, Egerdie B, et al. Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases. Supportive Care in Cancer. 2016;24(3):1327–1337. doi: 10.1007/s00520-015-2908-1
- Derzhavin VA, Bukharov AV, Yadrina AV, et al. Decompressive laminectomy in patients with spine metastasis. Siberian Journal of Oncology. 2021;20(4):57–63. doi: 10.21294/1814-4861-2021-20-4-57-63
- Yarikov AV, Makeeva OA, Kabardaev RM, et al. Drug and radiation therapy of metastatic spinal injury. Oncology Bulletin of the Volga region. 2022;13(4):68–86. doi: 10.32000/2078-1466-2022-4-68-86
- Brune K, Patrignani P. New insights into the use of currently available non-steroidal anti-inflammatory drugs. J Pain Res. 2015;8:105–118. doi: 10.2147/JPR.S75160
- Hunter TS, Robison C, Gerbino PP. Emerging Evidence in NSAID Pharmacology: Important Considerations for Product Selection. Am J Manag Care. 2015;21(7):139–147.
- Ushkalova EA, Zyryanov SK, Zalolochina KE. Safety and tolerability of NSAIDs: focus on aceclofenac. Meditsinskiy sovet. 2019;(9):110–120. doi: 10.21518/2079-701X-2019-9-110-120
- Smith HS, Voss B. Pharmacokinetics of intravenous ibuprofen implications of time of infusion in the treatment of pain and fever. Drugs. 2012;72(3):327–337. doi: 10.2165/11599230-000000000-00000
- Instructions for the medical use of the drug Neodolpasse [Internet]. Available from: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=db3c3a12-7dae-445e-b789-8f5616bc7345. Accessed: Jan 30, 2024 (In Russ).
- Plotnikova EY, Sinkova MN, Isakov LK, et al. Meloxicam — preferred non-steroid anti-inflammatory cyclooxygenase-2 inhibitor. Pharmateca. 2020;27(14):113–121. doi: 10.18565/pharmateca
- Amelin AV, Balyazin VA, Davydov OS, et al. Russian multicenter study of fixed combination of diclofenac and orphenadrine its efficacy and tolerance of in acute non-specific pain and radiculopathy relief. Russian Journal of Pain. 2022;20(1):33–41. doi: 10.17116/pain20222001133
- Pilipovich AA, Danilov AB. Therapy of pain of different genesis: new possibilities of diclofenac action. Therapy. 2019;5(4):103–112. doi: 10.18565/therapy.2019.4.103-112
- Amanullah A, Upadhyay A, Dhiman R, et al. Development and challenges of diclofenac-based novel therapeutics: Targeting cancer and complex diseases. Cancers (Basel). 2022;14(18):4385. doi: 10.3390/cancers14184385
- Gan TJ. Diclofenac: An update on its mechanism of action and safety profile. Curr Med Res Opin. 2010;26(7):1715–1731. doi: 10.1185/03007995.2010.486301
- Fu JL, Perloff MD. Pharmacotherapy for spine-related pain in older adults. Drugs Aging. 2022;39(7):523–550. doi: 10.1007/s40266-022-00946-x
- Abdel Shaheed C, Maher CG, Williams KA, et al. Efficacy and tolerability of muscle relaxants for low back pain: Systematic review and meta-analysis. Eur J Pain (United Kingdom). 2017;21(2):228–237. doi: 10.1002/ejp.907
- Chang WJ. Muscle Relaxants for acute and chronic pain. Phys Med Rehabil Clin N Am. 2020;31(2):245–254. doi: 10.1016/j.pmr.2020.01.005
- Nicol AL, Hurley RW, Benzon HT. Alternatives to Opioids in the Pharmacologic Management of Chronic Pain Syndromes: A Narrative Review of Randomized, Controlled, and Blinded Clinical Trials. Anesth Analg. 2017;125(5):1682–1703. doi: 10.1213/ANE.0000000000002426
- Huo L, Liu G, Deng B, et. al. Effect of use of NSAIDs or steroids during the acute phase of pain on the incidence of chronic pain: a systematic review and meta-analysis of randomised trials. Inflammopharmacol. 2023;32(2):1039–1058. doi: 10.1007/s10787-023-01405-8
- Park MK, Kang SH, Son JY, et al. Co-administered low doses of ibuprofen and dexamethasone produce synergistic antinociceptive effects on neuropathic mechanical allodynia in rats. J Pain Res. 2019;12:2959–2968. doi: 10.2147/JPR.S222095
- Redondo-Castro E, Navarro X. Chronic ibuprofen administration reduces neuropathic pain but does not exert neuroprotection after spinal cord injury in adult rats. Exp Neurol. 2014;252:95–103. doi: 10.1016/j.expneurol.2013.11.008
- Dill J, Patel AR, Yang XL, et al. A molecular mechanism for ibuprofen-mediated RhoA inhibition in neurons. J Neurosci. 2010;30(3):963–972. doi: 10.1523/JNEUROSCI.5045-09.2010
- Bugada D, Lavand’homme P, Ambrosoli AL, et al. Effect of postoperative analgesia on acute and persistent postherniotomy pain: a randomized study. J Clin Anesth. 2015;27(8):658–664. doi: 10.1016/j.jclinane.2015.06.008
- Oh JH, Seo HJ, Lee YH, et al. Do selective Cox-2 inhibitors affect pain control and healing after arthroscopic rotator cuff repair? A preliminary study. Am J Sports Med. 2018;46(3):679–686. doi: 10.1177/0363546517744219
- Sammour RN, Ohel G, Cohen M, et al. Oral naproxen versus oral tramadol for analgesia after cesarean delivery. Int J Gynecol Obstetrics. 2011;113(2):144–147. doi: 10.1016/j.ijgo.2010.11.024
- Guo X, Wang Z, Gao L, et al. Nonsteroidal antiinflammatory drugs versus tramadol in pain management following transsphenoidal surgery for pituitary adenomas: a randomized, double-blind, noninferiority trial. J Neurosurg. 2022;137(1):69–78. doi: 10.3171/2021.8.JNS211637
- Sorokina LS, Fomina DV, Semenkova MA, et al. Efficacy and safety of intravenous ibuprofen for early postoperative analgesia after cardiac surgery. Russian Journal of Cardiology and Cardiovascular Surgery. 2023;16(3):291–296. doi: 10.17116/kardio202316031291
- Sorokina LS, Ryabova DV, Koshek EA, et al. Efficiency and safety of a fixed combination of Orphenadrine and Diclofenac for postoperative analgesia in cardiac surgery patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(2):61–67. doi: 10.17116/jnevro202212202161
- Karelov AE, Khmara VM, Orozaliev IE, et al. Comparative assessment of analgesic efficacy of diclofenac and orfenadrine combination in abdominal and vertebral surgery. Russian Journal of Anesthesiology and Reanimatology. 2023;(5):52–57. doi: 10.17116/anaesthesiology202305152
- Zhou HS, Li TT, Pi Y, et al. Analgesic Efficacy of Intravenous Ibuprofen in the Treatment of Postoperative Acute Pain: A Phase III Multicenter Randomized Placebo-Controlled Double-Blind Clinical Trial. Pain Res Manag. 2023;2023:7768704. doi: 10.1155/2023/7768704
- Gukalov AA, Klypa TV, Mandel IA, et al. The use of a fixed combination of diclofenac and orphenadrine for postoperative pain relief in orthopedic patients. Pirogov Russian Journal of Surgery. 2023;(4):49–54. doi: 10.17116/hirurgia202304149
- Akbas S, Ozkan AS, Durak MA, et. Efficacy of intravenous paracetamol and ibuprofen on postoperative pain and morphine consumption in lumbar disc surgery: Prospective, randomized, double-blind, placebo-controlled clinical trial. Neurochirurgie. 2021;67(6):533–539. doi: 10.1016/j.neuchi.2021.04.019
- Gürkan Y, Yörükoğlu HU, Işık E, et al. The effect of ibuprofen on postoperative opioid consumption following total hip replacement surgery. Turk J Anaesthesiol Reanimation. 2019;47(1):31–34. doi: 10.5152/TJAR.2018.48265
- Kurushina OV, Barulin AE. New treatment options for piriformis syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(9):116–120. doi: 10.17116/jnevro2021121091116
- Shirokov VA, Potaturko AV, Terekhov NL, et al. Fixed combination of orphenadrine and diclofenac in the treatment of acute spondylogenic pain syndromes. Russian Journal of Pain. 2021;19(1):19–24. doi: 10.17116/pain20211901119
- Kiselev DV, Lavrukhin VV. The use of a fixed combination of diclofenac and orphenadrine in the treatment of acute pain syndrome in patients with discogenic lumbosacral radiculopathy and lumboischialgia. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(3):122–129. doi: 10.17116/jnevro2023123031122
- Bongiovanni T, Lancaster E, Ledesma Y, et al. Systematic Review and Meta-Analysis of the Association Between Non-Steroidal Anti-Inflammatory Drugs and Operative Bleeding in the Perioperative Period. J Am College Surg. 2021;232(5):765–790. doi: 10.1016/j.jamcollsurg.2021.01.005
- Losorelli SD, Scheffler P, Qian ZJ, et al. Post-tonsillectomy ibuprofen: Is there a dose-dependent bleeding risk? Laryngoscope. 2022;132(7):1473–1481. doi: 10.1002/lary.29876
- Fonseca ACG, Engelhardt MI, Huang ZJ, et al. Effect of changing postoperative pain management on bleeding rates in tonsillectomy patients. Am J Otolaryngol. 2018;39(4):445–447. doi: 10.1016/j.amjoto.2018.03.028
- Osojnik I, Kamenik M. The effect of diclofenac on bleeding, platelet function, and consumption of opioids following cardiac surgery. Braz J Cardiovasc Surg. 2020;35(2):160–168. doi: 10.21470/1678-9741-2019-0283
- Coluzzi F, LeQuang JAK, Sciacchitano S, et al. Look at Opioid-Induced Adrenal Insufficiency: A Narrative Review. Int J Mol Sci. 2023;24(5):4575. doi: 10.3390/ijms24054575
- Aydin O, Aldemir M, Taçyildiz I, et al. The metabolic and hormonal effects of perioperative ibuprofen treatment on surgical stress. Ulus Travma Derg. 2002;8(1):6–10.
- Chambrier C, Chassard D, Bienvenu J, et al. Cytokine and hormonal changes after cholecystectomy. Effect of ibuprofen pretreatment. Ann Surg. 1996;224(2):178–182. doi: 10.1097/00000658-199608000-00010